Meet Dr. Holmes
Welcome to my clinic. While I’m saddened that your situation brings you here, I’m happy that my years of experience in both clinical medicine and research can provide you with state of the art diagnosis and treatment for breast cancer and high risk breast cancer diseases.
MY GOALS FOR PARTNERSHIP WITH MY PATIENT
I have three goals:
- Deliver cutting edge diagnosis and therapy for breast cancer
- Assure you understand your disease and treatment to your level of emotional/intellectual comfort
- Hugs, laughs, humor to empower our teamwork together
My expertise is in the diagnosis and treatment of breast cancer and associated high risk breast cancer diseases including atypical hyperplasia, in situ cancer, and deleterious genetic mutations predisposing to breast cancer. I administer antihormone therapy, immunologic therapies, chemotherapy, bone-targeted therapies, etc in my clinic. I am involved in clinical research and participate in national clinical trials to provide access to new research treatments right here in my clinic. Be sure to ask me if you are eligible for a clinical trial. Additionally, I have a special interest in Supportive Care: protecting bone marrow, anti-vomiting medicines, etc.
My Mission Statement
- Undergraduate education: The College of William and Mary, Williamsburg, VA. BS, Chemistry. Phi Beta Kappa
- Medical School: Medical College of Virginia, Richmond, Virginia
- Internship, Residency: Internal Medicine, Hartford Hospital, Hartford, Connecticut
- Cancer Fellowship Training: UT MD Anderson Cancer Center, Houston, TX
RESEARCH & PUBLICATIONS
Thomas Edison said that research is 98% perspiration and 2% inspiration. I would modify that to say that it is also 50% the company you keep. At both UT MD Anderson and Texas Oncology/US Oncology, I had the good fortunate to be associated with colleagues of the highest intellectual and clinical standards. In this collaborative relationship, I had and have the opportunity to help answer many scientific questions. A few of the papers are listed.
After Internal Medicine Residency and before Cancer Fellowship Training, I worked I a small Connecticut Emergency Department at Willimantic Hospital in Willimantic, CT for 2 years.
After I completed my Fellowship Training, I joined the Faculty at UT MD Anderson. I worked at MD Anderson for nearly 15 years. During this time, I did clinical research and performed one of the two original clinical trials of paclitaxel (Taxol) which showed what a powerful anti-breast cancer medicine it was.
When my son was still a little boy, I needed more flexibility with my schedule but in a clinical practice that allowed me to do research. I joined Texas Oncology in 1998. Shortly after that, I had the honor of leading the Texas Oncology/US Oncology trial testing the long acting white blood cell growth factor, pegfilgrastim. Our trial was one of two trials that led to the approval of pegfilgrastim (Neulasta).
I would be hard pressed if I had to decide between research and teaching. My philosophy is that I want to teach my patients as much as they want to know about the disease they are confronting. Knowledge is power in the physical and mental commitment to dealing with breast cancer. I love finding just the PERFECT metaphor or analogy to simplify a complex oncology concept so that it is easily understood. However, I recognize that not ALL patients want to know everything. I want to learn about your preferences on our initial visit so I can be your most effective partner on this journey. But, not only with patients, but also sharing what I have learned with colleagues is a critical part of my own learning process.
I am again blessed with colleagues committed to education, especially Dr Joyce O’Shaughnessy and the Physicians Education Resource (LINK) who organize multiple annual conferences to which I am invited to lecture:
- School of Breast Oncology (SOBO) annually in November at Emory University Conference Center (LINK)
- International Congress on the Future of Breast Cancer (LINK)
Additionally Dr. William J. Gradishar, MD, who chairs:
- Lynn Sage Breast Cancer Symposium (LINK)